Earnings summaries and quarterly performance for U S PHYSICAL THERAPY INC /NV.
Executive leadership at U S PHYSICAL THERAPY INC /NV.
Board of directors at U S PHYSICAL THERAPY INC /NV.
Research analysts who have asked questions during U S PHYSICAL THERAPY INC /NV earnings calls.
Brian Tanquilut
Jefferies
4 questions for USPH
Joanna Gajuk
Bank of America
4 questions for USPH
Michael Petusky
Barrington Research
4 questions for USPH
Lawrence Solow
CJS Securities, Inc.
3 questions for USPH
Benjamin Rossi
JPMorgan Chase & Co.
2 questions for USPH
Constantine Davides
Citizens JMP
2 questions for USPH
Jared Haase
William Blair & Company
2 questions for USPH
Jared Haas
William Blair & Company, L.L.C.
1 question for USPH
Jiten Sanghai
Corre Partners Management, LLC
1 question for USPH
Larry Solow
CJS Securities
1 question for USPH
Ryan Quinn
Corre Partners Management, LLC
1 question for USPH
Recent press releases and 8-K filings for USPH.
- U.S. Physical Therapy, Inc. (USPH) announced a 10-year strategic alliance between its subsidiary partner, Metro Physical & Aquatic Therapy, and NYU Langone Health, which will integrate 60 outpatient physical therapy clinics into NYU Langone’s clinical services network in the New York metropolitan area. This alliance is anticipated to become operational within the next few months.
- USPH also announced the acquisition of an industrial injury prevention business for approximately $15.1 million, in which USPH acquired a 70% interest. This acquired business currently generates about $7.0 million in annual revenues.
- The financial impacts of the strategic alliance will be discussed during USPH's year-end earnings release and conference call, scheduled for February 25 and 26, 2026, respectively.
- U.S. Physical Therapy, Inc. (USPH) announced the acquisition of an industrial injury prevention business for approximately $15.1 million.
- USPH acquired a 70% interest in the business, with the current owner retaining 30%.
- The acquired business currently generates approximately $7.0 million in annual revenues.
- This acquisition further expands USPH's offerings in industrial injury prevention service lines.
- U.S. Physical Therapy, Inc. (USPH) announced a 10-year strategic alliance between its subsidiary, Metro Physical & Aquatic Therapy, and NYU Langone Health.
- As part of this agreement, Metro Physical Therapy's 60 existing outpatient physical therapy clinics will become part of NYU Langone's clinical services network, expanding access in Long Island and the New York metropolitan area.
- The alliance is expected to become operational within the next few months.
- USPH will discuss the financial impacts of this arrangement on its year-end earnings release and conference call, scheduled for February 25 and 26, 2026, respectively.
- U.S. Physical Therapy, Inc. (USPH) announced the acquisition of a physical therapy management services company on January 5, 2026.
- The acquired company manages a physical therapy practice with eight clinic locations, generating approximately $8.0 million in annual revenues and 66,000 annual visits.
- USPH acquired a 50% interest in the company, with the remaining 50% retained by the current owners.
- U.S. Physical Therapy, Inc. (USPH) announced the acquisition of a physical therapy management services company on January 5, 2026.
- The acquired company exclusively manages a physical therapy practice with eight clinic locations.
- This acquisition is projected to generate approximately $8.0 million in annual revenues and 66,000 in annual visits.
- USPH acquired a 50% interest in the company, with the current owners retaining the remaining 50%.
- U.S. Physical Therapy, Inc. (USPH) updated its investor presentation on November 18, 2025, providing an overview of the company's operations and financial position for the Q3 2025 period.
- As of September 30, 2025, USPH operated 779 owned/managed outpatient physical and occupational therapy clinics across 44 states.
- For the trailing twelve months ended September 30, 2025, the company reported $759 million in revenues and $92 million in Adjusted EBITDA. Revenue growth was 18% year-over-year for the nine months ended September 30, 2025, compared to the same period in 2024.
- USPH added 99 clinics, including de-novo and acquisitions, between October 1, 2024, and September 30, 2025.
- The company reported $112.9 million in cash and $175 million available for borrowings under its revolving facility as of June 30, 2024.
- U.S. Physical Therapy Inc. reported strong Q3 2025 financial results, with total patient visits increasing 18% year-over-year and physical therapy revenues growing 17.8% to $168.1 million. Adjusted EBITDA rose 13.2% to $23.9 million.
- The company reaffirmed its adjusted EBITDA guidance for full year 2025 to be in the range of $93 million to $97 million.
- Management anticipates a positive outlook for 2026, with the CMS final rule indicating a Medicare rate increase of 1.5% or better, reversing prior headwinds, and reinitiated opportunities from remote therapeutic monitoring.
- Acquisitions remain the primary capital allocation priority, especially in the Injury Prevention (IIP) segment due to better growth prospects, with 84 net PT facilities added in the last year.
- Operational efficiencies are improving, with PT salaries and related costs per visit decreasing $0.40 to $60.07 in Q3 2025, and initiatives like AI-driven documentation and front desk virtualization underway.
- U.S. Physical Therapy, Inc. (USPH) reported net income attributable to shareholders of $13.1 million for the third quarter of 2025, an increase from $6.6 million in the prior year, with earnings per share of $0.48.
- Adjusted EBITDA for Q3 2025 increased 13.2% to $23.9 million compared to $21.1 million in Q3 2024.
- Total revenue from physical therapy operations grew 17.8% to $168.1 million in Q3 2025, primarily driven by clinic additions.
- Management reaffirmed its full-year 2025 Adjusted EBITDA guidance in the range of $93.0 million to $97.0 million.
- The Board of Directors declared a quarterly dividend of $0.45 per share payable on December 12, 2025.
- USPH reported a strong second quarter for 2025, achieving record physical therapy volumes with 32.7 visits per clinic per day, up from 30.6 in Q2 last year, and an adjusted EBITDA of $26.9 million, an increase of $4.7 million compared to the prior year quarter.
- The company raised its full-year 2025 adjusted EBITDA guidance from a range of $88-$93 million to $93-$97 million, reflecting strong performance in the first half of the year.
- Both key segments demonstrated robust growth, with Injury Prevention (IIP) revenues increasing 22.6% (21.8% organically) and Physical Therapy (PT) revenues growing 17.3% to $168.3 million, largely driven by acquisitions.
- The Board of Directors authorized a share repurchase program of up to $25 million through December 31, 2026.
- For 2026, the company anticipates a positive Medicare rate increase of 1% to 1.75%, which is expected to contribute $2 million to $3 million to the top line and $1.5 million to $2.5 million to EBITDA, marking a shift from previous headwinds.
- U.S. Physical Therapy reported Net Income attributable to USPH shareholders of $13.1 million for the 2025 Third Quarter, an increase from $6.6 million in the 2024 Third Quarter, with earnings per share rising to $0.48.
- Adjusted EBITDA for the 2025 Third Quarter increased 13.2% to $23.9 million , while total revenue from physical therapy operations grew 17.8% to $168.1 million , supported by an 18.0% increase in total patient visits.
- The company expanded its clinic count, reaching 779 total clinics as of September 30, 2025, after adding 18 and closing 7 clinics in the 2025 Third Quarter. Additionally, on July 31, 2025, the company acquired a 60% equity interest in a three-clinic practice.
- Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million and declared a quarterly dividend of $0.45 per share.
Quarterly earnings call transcripts for U S PHYSICAL THERAPY INC /NV.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more